tiprankstipranks
Replimune Group (REPL)
NASDAQ:REPL
US Market
REPL
Replimune Group
RESEARCH TOOLSreports
Want to see REPL full AI Analyst Report?

Replimune Group (REPL) Stock News & Sentiment

505 Followers
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
Premium
Market News
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
14d ago
IMA
VTI
Replimune: Binary RP1 PDUFA Outcome and Funding Overhang Justify Hold Rating
Premium
Ratings
Replimune: Binary RP1 PDUFA Outcome and Funding Overhang Justify Hold Rating
1M ago
REPL
Replimune amends Hercules loan, strengthens funding runway
Premium
Company Announcements
Replimune amends Hercules loan, strengthens funding runway
3M ago
8K
REPL
Replimune Highlights RP1, RP2 Progress Ahead of JPM Conference
Premium
Company Announcements
Replimune Highlights RP1, RP2 Progress Ahead of JPM Conference
4M ago
8K
REPL
Replimune Group Reports Increased Losses Amid R&D Expansion
Premium
Company Announcements
Replimune Group Reports Increased Losses Amid R&D Expansion
6M ago
REPL
Positive Outlook for Replimune Group: Buy Rating Affirmed on Promising RP1 + Opdivo Therapy and Strong Financial Position
Premium
Ratings
Positive Outlook for Replimune Group: Buy Rating Affirmed on Promising RP1 + Opdivo Therapy and Strong Financial Position
6M ago
REPL
Replimune’s Promising Study on Metastatic Uveal Melanoma: A Potential Game Changer?
Premium
Company Announcements
Replimune’s Promising Study on Metastatic Uveal Melanoma: A Potential Game Changer?
6M ago
REPL
More REPL News >

REPL News on the Web

Replimune Group (REPL) was downgraded to a Hold Rating at Leerink Partners
TipRanks News
Bearish
Replimune stock collapses 64% following FDA rejection
TheStreet.com
Neutral
Replimune Faces Legal Scrutiny After FDA Setback Raises Recovery Questions for Investors
Market Chameleon
Bearish
Replimune Group (REPL) Faces Downgrades After FDA Rejects Melanoma Drug RP1
GuruFocus News
Neutral
Replimune melanoma therapy rejected by FDA, shares plunge
Proactive Investors
Bearish
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
Zacks
Bearish
Nike downgraded, Starbucks upgraded: Wall Street’s top analyst calls
TipRanks News
Bearish
Video: Goldman slips after bank kicks off earnings season
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
REPL
Sector Average
Media Buzz
This Week3 articles
Weekly Average8.75 articles
News Sentiment
This Week0%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REPL’s Media Buzz Sentiment?
3 articles about REPL were published this week. In an average week, 8.75 articles are published.
    What is REPL’s weekly average amount of articles?
    In an average week, 8.75 articles about REPL are published.
      What is REPL’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      TVTXTravere Therapeutics
      HVOOpen Orphan Plc
      PBMPsyence Biomedical
      QDELQuidelOrtho
      Showing the stocks with the most bullish news sentiment over the past week